YL-529

N/A

Report date: 2022/02/15 16:47:24
NME

Base Information

Drug NameYL-529
Drug Alias NameYL-529
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRAF serine/threonine protein kinase inhibitorsVascular endothelial growth factor receptor antagonists
TargetsRAF serine/threonine protein kinaseVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China School Of Pharmcy Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesWest China School Of Pharmcy Sichuan University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A